Mader, Mary M
Eli Lilly (United States)
2 papers on CoChatORCID 0000-0001-8832-7187
Most cited papers
- Verified
The promise and peril of chemical probes
Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology
Click Chemistry and ApplicationsComputational Drug Discovery Methods
Cited by 839
- Verified
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity
Campbell, R. M., Anderson, B. D., Brooks, N. A., Brooks, H. B., Chan, E. M., De Dios, A., Gilmour, R., Graff, J. R., Jambrina, E., Mader, M., et al. (2014) · Molecular Cancer Therapeutics
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 121
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free